Physician profile
Fermin C Garcia
NPI 1780672477
$684,405.37
in general payments reported to CMS, 2019-2025
21 companies · $71K in 2025
The $71K reported for 2025 was more than what 97% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219K · 2020: $37K · 2021: $34K · 2022: $134K · 2023: $103K · 2024: $86K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $205K · Travel and Lodging: $22K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,500 · Food and Beverage: $8,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $204,862.50 |
| Travel and Lodging | $21,718.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,881.25 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,500.00 |
| Food and Beverage | $8,208.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $352,875.08 | 2019-2024 | Carto 3 |
| Abbott Laboratories | $170,981.54 | 2019-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Ensite Precision |
| Biosense Webster, INC. | $65,601.11 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Nuvision Ice Catheter |
| Boston Scientific Corporation | $38,560.06 | 2019-2025 | Farapulse, Versacross Access Solution, General - Therapies |
| Biotronik INC. | $24,529.98 | 2019-2025 | |
| Medtronic, INC. | $13,354.85 | 2021-2025 | Arctic Front Advance, Sphere-9, Affera Mapping System |
| Baylis Medical Company INC | $11,550.90 | 2021 | |
| Medtronic Vascular, INC. | $5,305.57 | 2019 | |
| Impulse Dynamics (USA) INC. | $594.86 | 2022-2024 | Optimizer, Optimizer |
| Biosig Technologies, INC. | $500.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $151.85 | 2019-2020 | |
| Stryker Corporation | $73.82 | 2021 | |
| Johnson & Johnson Health Care Systems INC. | $71.03 | 2022 | |
| Atricure, INC. | $59.89 | 2020 | |
| Janssen Biotech, INC. | $39.54 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $37.51 | 2022 | |
| Cvrx, INC. | $27.83 | 2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals Lp | $25.80 | 2024 | Wainua |
| Kestra Medical Technology Services, INC. | $23.58 | 2025 | Assure Wcd |
| Cardiva Medical, INC. | $21.18 | 2019 | |
| Siemens Medical Solutions USA, INC. | $19.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fermin Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.